UROVANT SCIENCES
Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. Our lead product candidate is vibegron, an oral, once-daily, small molecule beta-3 agonist, being developed for overactive bladder (OAB), OAB in men with benign prostatic hyperplasia (BPH) and pain associated with irritable bowel syndrome (IBS). Urovantโs second investigational product candidate, URO-902, is a novel gene therapy for patients with overactive bladder (OAB) symptoms who have failed oral pharmacologic therapy.
UROVANT SCIENCES
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.urovant.com
Total Employee:
11+
Status:
Active
Contact:
949-226-6029
Email Addresses:
[email protected]
Total Funding:
100 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager Nginx Euro Amazon IPv6
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Current Employees Featured
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - Urovant Sciences
Key Employee Changes
Official Site Inspections
http://www.urovant.com Semrush global rank: 975.57 K Semrush visits lastest month: 35.82 K
- Host name: ec2-107-20-11-174.compute-1.amazonaws.com
- IP address: 107.20.11.174
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149